{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,18]],"date-time":"2026-07-18T18:32:43Z","timestamp":1784399563223,"version":"3.55.0"},"reference-count":23,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.saa.2019.117290","type":"journal-article","created":{"date-parts":[[2019,6,19]],"date-time":"2019-06-19T03:07:03Z","timestamp":1560913623000},"page":"117290","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Novel spectral manipulations for determinations of Tolnaftate along with related toxic compounds: Drug profiling and a comparative study"],"prefix":"10.1016","volume":"223","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6526-4419","authenticated-orcid":false,"given":"Raghda A.","family":"Emam","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maha M.","family":"Abdelrahman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eglal A.","family":"Abdelaleem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nouruddin W.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.saa.2019.117290_bb0005","series-title":"Her Majesty's","author":"BP, The British Pharmacopoeia","year":"2007"},{"key":"10.1016\/j.saa.2019.117290_bb0010","series-title":"The complete drug reference","author":"Martindale","year":"2007"},{"key":"10.1016\/j.saa.2019.117290_bb0015","series-title":"Dermatotoxicology","first-page":"864","author":"Marzulli","year":"1991"},{"key":"10.1016\/j.saa.2019.117290_bb0020","series-title":"Hazardous Materials Toxicology-Clinical Principles of Environmental Health","first-page":"1098","year":"1992"},{"key":"10.1016\/j.saa.2019.117290_bb0025","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0731-7085(99)00280-0","article-title":"Analysis of some antifungal drugs by spectrophotometric and spectrofluorometric methods in different pharmaceutical dosage forms","volume":"22","author":"Khashaba","year":"2000","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2019.117290_bb0030","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s002160051606","article-title":"Assay of Tolnaftate and related impurities by isocratic supercritical fluid chromatography","volume":"367","author":"Patil","year":"2000","journal-title":"Fresen. J. Anal. Chem."},{"key":"10.1016\/j.saa.2019.117290_bb0035","author":"National Center for Biotechnology Information"},{"key":"10.1016\/j.saa.2019.117290_bb0040","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/0039-9140(93)80019-N","article-title":"Spectrophotometric methods for the determination of Tolnaftate","volume":"40","author":"Sastry","year":"1993","journal-title":"Talanta"},{"key":"10.1016\/j.saa.2019.117290_bb0045","doi-asserted-by":"crossref","first-page":"9","DOI":"10.33899\/edusj.2009.57685","article-title":"Indirect spectrophotometric determination of Tolnaftate in pharmaceutical preparations","volume":"22","author":"Tahssen","year":"2009","journal-title":"J. Educ. Sci."},{"key":"10.1016\/j.saa.2019.117290_bb0050","first-page":"207","article-title":"Development of UV spectrophotometric method for qualitative and quantitative estimation of Tolnaftate in different formulations","volume":"5","author":"Bhoyar","year":"2012","journal-title":"Res. J. Pharm. Technol."},{"key":"10.1016\/j.saa.2019.117290_bb0055","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/0731-7085(93)80079-G","article-title":"A liquid chromatographic method for the determination of Tolnaftate in pharmaceutical formulations","volume":"11","author":"Dash","year":"1993","journal-title":"J. Pharm. Biomed. Anal."},{"key":"10.1016\/j.saa.2019.117290_bb0060","first-page":"16","article-title":"Reversed phase HPLC determination of Tolnaftate in cream and topical solution","volume":"52","author":"Zarapkar","year":"1990","journal-title":"Ind. J. Pharm. Sci."},{"key":"10.1016\/j.saa.2019.117290_bb0065","first-page":"327","article-title":"Assay of Tolnaftate in human skin samples after in vitro penetration studies using high performance liquid chromatography","volume":"67","author":"Kezutyte","year":"2010","journal-title":"Acta Pol. Pharm."},{"key":"10.1016\/j.saa.2019.117290_bb0070","first-page":"250","article-title":"Liquid chromatographic technique for stability indicating analytical method development and validation of salicylic acid and Tolnaftate in pharmaceutical ointment by high performance","volume":"2","author":"Sheikh","year":"2012","journal-title":"Int. J. Sci. Res. Pub."},{"key":"10.1016\/j.saa.2019.117290_bb0075","first-page":"671","article-title":"A validated simultaneous RP-HPLC method for determination of betamethasone dipropionate and Tolnaftate in combined semisolid formulation","volume":"1","author":"Saha","year":"2009","journal-title":"Int. J. ChemTech Res."},{"key":"10.1016\/j.saa.2019.117290_bb0080","first-page":"17","article-title":"Development and validation of analytical method for simultaneous estimation of betamethasone dipropionate, Tolnaftate, Iodochlorhydroxyquin in pharmaceutical dosage form","volume":"2","author":"Bapna","year":"2015","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.saa.2019.117290_bb0085","series-title":"Proceeding of the International Conference on Harmonization","article-title":"Stability testing of new drug substances and products","author":"ICH Q1A (R2)","year":"2003"},{"key":"10.1016\/j.saa.2019.117290_bb0090","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1081\/PDT-120003494","volume":"7","author":"Waterman","year":"2002","journal-title":"Pharm. Dev. Technol."},{"key":"10.1016\/j.saa.2019.117290_bb0095","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1080\/00397919108021779","author":"Kalkote","year":"1991","journal-title":"Synth. Commun."},{"key":"10.1016\/j.saa.2019.117290_bb0100","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.saa.2015.10.037","article-title":"A comparative study of ICH validated novel spectrophotometric techniques for resolving completely overlapping spectra of quaternary mixtures","volume":"154","author":"Ali","year":"2016","journal-title":"Spectrochim. Acta, Part A"},{"key":"10.1016\/j.saa.2019.117290_bb0105","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/1752-153X-7-152","article-title":"Resolution of five-component mixture using mean centering ratio and inverse least squares chemometrics","volume":"7","author":"Issa","year":"2013","journal-title":"Chem. Cent. J."},{"key":"10.1016\/j.saa.2019.117290_bb0110","first-page":"318","article-title":"Validated RP-HPLC and TLC-densitometric methods for analysis of ternary mixture of cetylpyridinium chloride, chlorocresol and lidocaine in oral antiseptic formulation","volume":"54","author":"Abdelwahab","year":"2015","journal-title":"J. Chromatogr. Sci."},{"key":"10.1016\/j.saa.2019.117290_bb0115","series-title":"Validation of Analytical Procedures, Proceedings of the International Conference on Harmonization, Geneva","first-page":"Q2","year":"2005"}],"container-title":["Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142519306808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1386142519306808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T01:15:44Z","timestamp":1761354944000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1386142519306808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":23,"alternative-id":["S1386142519306808"],"URL":"https:\/\/doi.org\/10.1016\/j.saa.2019.117290","relation":{},"ISSN":["1386-1425"],"issn-type":[{"value":"1386-1425","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel spectral manipulations for determinations of Tolnaftate along with related toxic compounds: Drug profiling and a comparative study","name":"articletitle","label":"Article Title"},{"value":"Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.saa.2019.117290","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"117290"}}